WS Value & Dossier GmbH

WS Value & Dossier GmbH advises innovative pharmaceutical and biotech companies in the AMNOG process. Based on our long and valueable expertise, our qualified employees and our versatile partners, we support you in strategy development, in preparing your benefit dossier for the G-BA evaluation, and in price negotiations with the GKV-Spitzenverband. Both the motivation and the objectives are always the optimized reimbursement for your new product. Our focus is on detailed process experience and innovative, interdisciplinary approaches.